Clinical Trial Update: Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI [Phase 4]

View source ↗

Summary

A Phase 4 trial compares ticagrelor versus clopidogrel in high-risk non-ST-elevation acute coronary syndrome patients undergoing early PCI; the update does not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Non-st-elevation Acute Coronary Syndrome

Drugs mentioned

• Clopidogrel (Plavix) (clopidogrel)
• ticagrelor (Brilinta) (ticagrelor)

Snippet

Sponsor: RenJi Hospital | Conditions: Acute Coronary Syndrome | Phase 4 | Status: UNKNOWN